<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Raynauds_Disease.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:06 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1254008">
<meta name="Category" content="Concern">
<meta name="Article" content="Raynauds_Disease">
<title>Enfermedad de Raynaud-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Enfermedad de Raynaud</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Raynauds_Disease.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Digiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients
with Raynaud&#8217;s phenomenon: a double-blind, controlled, prospective study. <em>Am J
Med</em> 1989;86:158&#8211;64.</li>

<li class="Ref">Aylward M. Hexopal in Raynaud&#8217;s disease. <em>J Int Med Res</em>
1979;7:484&#8211;91.</li>

<li class="Ref">Holti G. An experimentally controlled evaluation of the effect of inositol
nicotinate upon the digital blood flow in patients with Raynaud&#8217;s phenomenon. <em>J Int
Med Res</em> 1979;7:473&#8211;83.</li>

<li class="Ref">Ring EF, Bacon PA. Quantitative thermographic assessment of inositol
nicotinate therapy in Raynaud&#8217;s phenomenon. <em>J Int Med Res</em>
1977;5:217&#8211;22.</li>

<li class="Ref">Belch JJF, Shaw B, O&#8217;Dowd A, et al. Evening primrose oil (Efamol) in the
treatment of Raynaud&#8217;s phenomenon: A double-blind study. <em>Throm Haemost</em>
1985;54(2):490&#8211;4.</li>

<li class="Ref">Gasser P, Martina B, Dubler B. Reaction of capillary blood cell velocity in
nailfold capillaries to L-carnitine in patients with vasospastic disease. <em>Drugs Exptl Clin
Res</em> 1997;23:39&#8211;43.</li>

<li class="Ref">Leppert J, Aberg H, Levin K, et al. The concentration of magnesium in
erythrocytes in female patients with primary Raynaud&#8217;s phenomenon; fluctuation with the
time of year. <em>Angiology</em> 1994;45:283&#8211;8.</li>

<li class="Ref">Smith WO, Hammarsten JF, Eliel LP. The clinical expression of magnesium
deficiency. <em>JAMA</em> 1960;174:77&#8211;8.</li>

<li class="Ref">Turlapaty P, Altura BM. Magnesium deficiency produces spasms of coronary
arteries; relationship to etiology of sudden death ischemic heart disease. <em>Science</em>
1980;208:198&#8211;200.</li>

<li class="Ref">Kleijnen J, Knipschild P. Ginkgo biloba. <em>Lancet</em> 1992;340:1136&#8211;9
[review].</li>

<li class="Ref">Clement JL, Livecchi G, Jimenez C, et al. Modifications vasomotrices des
extr&#233;mit&#233;s lors l&#8217;exposition &#224; des conditions thermiques
d&#233;favorables. M&#233;thodologie et r&#233;sultant de l&#8217;&#233;tude de
l&#8217;extrait de <em>Ginkgo biloba. Acutal Angiol</em> 1982;7:3&#8211;8.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Raynauds_Disease.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:06 GMT -->
</html>

